<DOC>
	<DOCNO>NCT02081183</DOCNO>
	<brief_summary>This study compare efficacy CellCept [ 0.5-2 gram per day ( g/day ) orally ( p.o . ) ] cyclophosphamide [ 0.5-1 gram per square meter ( g/m2 ) quarterly ] maintenance treatment patient lupus nephritis . All patient receive induction treatment cyclophosphamide ( 0.5-1g/m2 monthly ) 6 month , randomize maintenance phase study 6 month , follow 6 month treatment-free follow-up . The anticipated time study treatment 12 month .</brief_summary>
	<brief_title>A Study Evaluate Efficacy CellCept ( Mycophenolate Mofetil ) Patients With Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>adult patient &gt; =18 year age ; diagnosis systemic lupus erythematosus lupus nephritis ( class III , IV V ) . patient receive cytotoxic drug previous 8 week ; systemic infection ; hepatitis B C , HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>